Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR.

Am J Med. 1977 May;62(5):707-14.

PMID:
193398
2.
3.

High-density lipoprotein cholesterol concentration and other serum lipids in an isolated island community free of coronary heart disease.

Miller GJ, Koplan JP, Morgan P, Ashcroft MT, Moinuddin M, Beckles GL.

Int J Epidemiol. 1979 Sep;8(3):219-25.

PMID:
231577
4.

Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.

Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR.

Ann Intern Med. 1977 Oct;87(4):393-7.

PMID:
199096
5.
6.

Cholesterol, lipoproteins, and coronary heart disease in women.

Bush TL, Fried LP, Barrett-Connor E.

Clin Chem. 1988;34(8B):B60-70. Review.

PMID:
3042201
7.

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ.

Circulation. 1977 May;55(5):767-72.

PMID:
191215
8.

Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise.

Brownell KD, Bachorik PS, Ayerle RS.

Circulation. 1982 Mar;65(3):477-84.

PMID:
7055869
9.

Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.

Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Ogilvie JT, Hazzard WR, Knopp RH.

Atherosclerosis. 1981 Apr;39(1):111-24.

PMID:
6941788
10.

Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols.

Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB.

Am J Cardiol. 1980 Oct;46(4):649-54.

PMID:
7416024
11.

Lipids and risk of coronary heart disease. The Framingham Study.

Castelli WP, Anderson K, Wilson PW, Levy D.

Ann Epidemiol. 1992 Jan-Mar;2(1-2):23-8.

PMID:
1342260
12.

Lipoproteins, cardiovascular disease, and death. The Framingham study.

Gordon T, Kannel WB, Castelli WP, Dawber TR.

Arch Intern Med. 1981 Aug;141(9):1128-31.

PMID:
7259370
13.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group.

Circulation. 2001 Sep 4;104(10):1108-13.

14.
15.
17.

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ.

Clin Chem. 2004 Jul;50(7):1189-200. Epub 2004 Apr 23.

18.

Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?

LaRosa JC.

Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3.

PMID:
1617306
19.

Relation of angiographically defined coronary artery disease to serum lipoprotein levels.

O'Sullivan JJ, Matthew A, Conroy RM, Erwin RJ, Duggan PF.

Clin Cardiol. 1990 Dec;13(12):841-4.

20.

Severity of coronary atherosclerosis related to lipoprotein concentration.

Jenkins PJ, Harper RW, Nestel PJ.

Br Med J. 1978 Aug 5;2(6134):388-91.

Supplemental Content

Support Center